New hexavalent vaccine protects children against 6 diseases
On 26 December 2018, Sanofi and Merck jointly announced (pdf) FDA approval for a new hexavalent vaccine called Vaxelis. The new vaccine was developed to vaccinate children aged 6 weeks to 4 years old to protect them against diphtheria, tetanus, pertussis… Read More »New hexavalent vaccine protects children against 6 diseases